Hemofiltration compared to hemodialysis for acute kidney injury: systematic review and meta-analysis

Critical Care

Volumn 16, Issue 4, 2012, Pages

  Friedrich, Jan O ^a,b,c,d   Wald, Ron ^a,b,c   Bagshaw, Sean M ^e   Burns, Karen E A ^a,b,c,d   Adhikari, Neill K J ^a,d,f  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f Sunnybrook Health Sciences Centre   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERTENSIVE AGENT;

ACUTE KIDNEY FAILURE; ARTICLE; CONFIDENCE INTERVAL; CONTINUOUS RENAL REPLACEMENT THERAPY; EMBASE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; MEDLINE; META ANALYSIS; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SURVIVOR; SYSTEMATIC REVIEW; TREATMENT OUTCOME; ACUTE KIDNEY INJURY; RENAL REPLACEMENT THERAPY;

ACUTE KIDNEY INJURY; HEMOFILTRATION; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 84864501927     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc11458     Document Type: Article

References (81)

1. Uchino S, Kellum J, Bellomo R, Doig GS, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Ronco C, . for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators Acute Renal Failure in Critically Ill Patients: A multinational, multicenter study. JAMA 2005, 294:813-818. 10.1001/jama.294.7.813, 16106006, for the Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) Investigators.
2. Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G, Ellis P, Guzman J, Marshall J, Parrillo JE, Skrobik Y, Kumar A, . the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 2009, 35:871-881. 10.1007/s00134-008-1367-2, 19066848, the Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group.
3. Wald R, Quinn RR, Luo J, Li P, Scales DC, Mamdani MM, Ray JG, . for the University of Toronto Acute Kidney Injury Research Group Chronic dialysis and death among survivors of acute kidney injury requiring dialysis. JAMA 2009, 302:1179-1185. 10.1001/jama.2009.1322, 19755696, for the University of Toronto Acute Kidney Injury Research Group.
4. The RENAL Replacement Therapy Study Investigators Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361:1627-1638. The RENAL Replacement Therapy Study Investigators.
5. The VA/NIH Acute Renal Failure Trial Network Intensity of renal support in critically ill patients with acute kidney injury. N Eng J Med 2008, 359:7-20. The VA/NIH Acute Renal Failure Trial Network.
6. Van Wert R, Friedrich JO, Scales DC, Wald R, Adhikari NKJ. High-dose renal replacement therapy for acute kidney injury: systematic review and meta-analysis. Crit Care Med 2010, 38:1360-1369. addendum Crit Care Med 2010, 38:2424-2425.
7. Jun M, Heerspink HJL, Ninomiya T, Gallagher M, Bellomo R, Myburgh J, Finfer S, Palevsky PM, Kellum JA, Perkovic V, Cass A. Intensities of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2010, 5:956-963. 10.2215/CJN.09111209, 2879310, 20395356.
8. Brunet S, Leblanc M, Geadah D, Parent D, Courteau S, Cardinal J. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999, 34:486-492. 10.1016/S0272-6386(99)70076-4, 10469859.
9. Ronco C, Tetta C, Mariano F, Wratten ML, Bonello M, Bordoni V, Cardona X, Inguaggiato P, Pilotto L, d'Intini V, Bellomo R. Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. Artif Organs 2003, 27:792-801. 10.1046/j.1525-1594.2003.07289.x, 12940901.
10. Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, Tan I, Bouman C, Macedo E, Gibney N, Tolwani A, Oudemans-van Straaten H, Ronco C, Kellum JA. Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med 2007, 33:1563-1570. 10.1007/s00134-007-0754-4, 17594074.
11. Renal Study Investigators Renal replacement therapy for acute kidney injury in Australian and New Zealand intensive care units: a practice survey. Crit Care Resusc 2008, 10:225-230. Renal Study Investigators.
12. Gatward JJ, Gibbon GJ, Wrathall G, Padkin A. Renal replacement therapy for acute renal failure: a survey of practice in adult intensive care units in the United Kingdom. Anaesthesia 2008, 63:959-966. 10.1111/j.1365-2044.2008.05514.x, 18549413.
13. Overberger P, Pesacreta M, Palevsky PM, . for the VA/NIH Acute Renal Failure Trial Network Management of Renal Replacement Therapy in Acute Kidney Injury: a survey of practitioner prescribing practices. Clin J Am Soc Nephrol 2007, 2:623-630. 10.2215/CJN.00780207, 2325917, 17699474, for the VA/NIH Acute Renal Failure Trial Network.
14. Flores FX, Brophy PD, Symons JM, Fortenberry JD, Chua AN, Alexander SR, Mahan JD, Bunchman TE, Blowey D, Somers MJG, Baum M, Hackbarth R, Chand D, McBryde K, Benfield M, Goldstein SL. Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group. Pediatr Nephrol 2008, 23:625-630. 10.1007/s00467-007-0672-2, 18228045.
15. Zwillman M, Adhikari NK, Meade MO, Hladunewich M, Piquette D, Friedrich JO. Survey of continuous renal replacement therapy in Canadian intensive care units [Abstract]. Inten Care Med 2006, 32:S161.
16. Mills EJ, Chan A-W, Wu P, Vail A, Guyatt GH, Altman DG. Design, analysis, and presentation of crossover trials. Trials 2009, 10:27. 10.1186/1745-6215-10-27, 2683810, 19405975.
17. Friedrich JO, Adhikari NK, Beyene J. The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study. BMC Med Res Methodol 2008, 8:32. 10.1186/1471-2288-8-32, 2430201, 18492289.
18. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002, 21:1539-1558. 10.1002/sim.1186, 12111919.
19. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560. 10.1136/bmj.327.7414.557, 192859, 12958120.
20. Elbourne DR, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2002, 31:140-149. 10.1093/ije/31.1.140, 11914310.
21. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med 1993, 21:28-338.
22. Alamartine E, de Filippis JP, Toulon J, Berthoux F. On-line continuous venovenous hemodiafiltration: a technique for the control of ultrafiltration and convection during continuous renal replacement therapy. Ren Fail 1994, 16:707-714. 10.3109/08860229409044900, 7899582.
23. Pettila V, Tiula E. Intermittent hemodiafiltration in acute renal failure in critically ill patients. Clin Nephrol 2001, 56:324-331.
24. Morgera S, Slowinski T, Melzer C, Sobottke V, Vargas-Hein O, Volk T, Zuckermann-Becker H, Wegner B, Mu{double acute}ller JM, Baumann G, Kox WJ, Bellomo R, Neumayer H-H. Renal replacement therapy with high-cutoff hemofilters: impact of convection and diffusion on cytokine clearances and protein status. Am J Kidney Dis 2004, 43:444-453. 10.1053/j.ajkd.2003.11.006, 14981602.
25. Daud KM, Leong GB, Visvanathan R. Acute dialytic support for the critically ill: continuous venovenous haemodialysis versus continuous venovenous haemofiltration. Int Med J 2006, 13:37-42.
26. Saudan P, Niederberger M, De Seigneux S, Romand J, Pugin J, Perneger T, Martin PY. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute kidney failure. Kidney Int 2006, 70:1312-1317. 10.1038/sj.ki.5001705, 16850022.
27. Chang JW, Lee HK, Yang WS, Kim SB, Park S-K, Lee SK, Park JS. No difference in clearance and survival between continuous hemodiltration and hemodiafiltration at the same net effluent in patients with acute renal failure [Abstract]. Crit Care Med 2009, 37(Suppl):A473.
28. Ratanarat R, Rugsasuk S, Chanchairujira T, Athirakul K, Vasuvattakul S. Effect of prolonged intermittent renal replacement therapy on phosphate kinetics in critically ill patients with acute kidney injury [Abstract]. J Am Soc Nephrol 2009, 20:602A.
29. Ratanarat R, Chaipruckmalakarn T, Laowahutanont N, Larpparisuth N, Vasuvattakul S. Efficacy and hemodynamic outcome of prolonged intermittent renal replacement therapy (PIRRT) in critically ill patients: a preliminary report. J Med Assoc Thai 2012, 95(Suppl 2):S265-S271.
30. Wald R, Friedrich JO, Bagshaw SM, Burns KEA, Garg AX, Hladunewich MA, House AA, Lapinsky S, Pannu NI, Richardson RM, Thorpe K, Adhikairi N. The optimal mode of renal replacement therapy in acute kidney injury (OMAKI): a pilot randomized controlled trial of CVVH vs. CVVHD [Abstract]. J Am Soc Nephrol 2011, 22:10B.
31. Maher ER, Hart L, Levy D, Scoble JE, Baillod RA, Sweny P, Varghese Z, Moorhead JF. Comparison of continuous arteriovenous haemofiltration and haemodialysis in acute renal failure [Letter]. Lancet 1988, 1:129.
32. Alarabi AA, Taube A, Danielson BG, Wikstroem B. Continuous ateriovenous haemodialysis and haemofiltration in intensive care acute renal failure patients. Int Urol Nephrol 1992, 24:657-664. 10.1007/BF02551303, 1289277.
33. Jeffrey RF, Khan AA, Prabhu P, Todd N, Goutcher E, Will EJ, Davison AM. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system. Artif Organs 1994, 18:425-428. 10.1111/j.1525-1594.1994.tb02228.x, 8060251.
34. Kellum JA, Johnson JP, Kramer D, Palevsky P, Brady JJ, Pinsky MR. Diffusive vs. convective therapy: effects on mediators of inflammation in patients with severe systemic inflammatory response syndrome. Crit Care Med 1998, 26:1995-2000. 10.1097/00003246-199812000-00027, 9875910.
35. Garcia-Fernandez N, Lavilla FJ, Rocha E, Purroy A. Haemostatic changes in systemic inflammatory response syndrome during continuous renal replacement therapy. J Nephrol 2000, 13:282-289.
36. Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE. Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 2000, 28:1161-1165. 10.1097/00003246-200004000-00041, 10809299.
37. Wynckel A, Cornillet J, Bene B, Stolz A, Lepouse C, Paris B, Chanard J. Improved removal of small proteins using continuous venovenous hemofiltration to treat acute renal failure. ASAIO J 2004, 50:81-84. 10.1097/01.MAT.0000104823.48673.BD, 14763496.
38. Ricci Z, Ronco C, Bachetoni A, D'amico G, Rossi S, Alessandri E, Rocco M, Pietropaoli P. Solute removal during continuous renal replacement therapy in critically ill patients: convection versus diffusion. Crit Care 2006, 10:R67. 10.1186/cc4903, 1550874, 16646985.
39. Davies HT, Leslie G, Pereira SM, Webb SA. A randomized comparative crossover study to assess the affect on circuit life of varying pre-dilution volume associated with CVVH and CVVHDF. Int J Artif Organs 2008, 31:221-227.
40. Li Y, Hu ZJ, Li CX, Cui Y, Dai QC, Guo JP. A clinical study on different modalities of blood purification for the treatment of sepsis [Chinese]. Chin Crit Care Med 2009, 21:369-370.
41. Marchionna N, Floris M, Brendolan A, Nalesso F, Zanella M, Ronco C. Solutes removal during continuous renal replacement therapy in critically ill patients with a new high polysulfone-based hemofilter (CUREFLO®): convection vs. diffusion [Abstract]. J Am Soc Nephrol 2010, 21:893A.
42. Raja R, Karmer M, Goldstein S, Caruana R, Lerner A. Comparison of continuous arteriovenous hemofiltration and continuous arteriovenous dialysis in critically ill patients. ASAIO Trans 1986, 435-436.
43. Zobel G, Ring E, Zobel V. Continuous arteriovenous renal replacement systems for critically ill children. Ped Nephrol 1989, 3:140-143.
44. Bellomo R, Ernest D, Parkin G, Boyce N. Clearance of vancomycin during continuous arteriovenous hemodiafiltration. Crit Care Med 1990, 18:181-183. 10.1097/00003246-199002000-00011, 2298011.
45. Hirasawa H, Sugai T, Ohtake Y, Oda S, Shiga H, Matsuda K, Kitamura N. Continuous hemofiltration and hemodiafiltration in the management of multiple organ failure. Contrib Nephrol 1991, 93:42-46.
46. Valtonen M, Tiula E, Neuvonen PJ. Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure. J Antimicrob Chemother 1997, 40:695-700. 10.1093/jac/40.5.695, 9421318.
47. Meloni C, Morosetti M, Turani F, Palombo G, Meschini L, Zupancich E, Taccone-Gallucci M, Di Giulio S, Casciani CU. Cardiac function and oxygen balance in septic patients during continuous hemofiltration. Blood Purif 1998, 16:140-146. 10.1159/000014327, 9681156.
48. Booth M, Fox C, Dobb G. Energy losses associated with continuous venovenous haemodiafiltration in intensive care patients [Abstract]. Br J Anaesth 1995, 74(Suppl 1):109.
49. Favre H, Blanc E, Emonet S, Claeysen D. Treatment of acute renal insufficiency with continuous veno-venous haemofiltration; importance of precise fluid balance control [French] [Abstract]. Schweiz Med Wochenschr 1996, 126(Suppl 81):17.
50. Cole L, Bellomo R, Baldwin I. A randomized, prospective, crossover study of the hemodynamic effects of high-volume hemofiltration in patients with septic shock [Conference Proceedings]. Blood Purif 1998, 16:113-114.
51. Dilek K, Ersoy A, Gu{double acute}llu{double acute}lu{double acute} M, Aslanhan I, Emir G, Dalky{hook above}ly{hook above}ç E, Karabulut Y, Usta M, Ilcol Y, Yavuz M, Yurtkuran M. Crush syndrome developing acute renal failure in the Marmar earthquake: the comparison of the effects of different hemodialysis approaches on renal functions and mortality rates [Abstract]. Nephol Dial Transplant 2000, 15:A82.
52. Lins RL, Elseviers MM, Van der Niepen P, Hoste E, Malbrain ML, Damas P, Devriendt J, . SHARF investigators Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephol Dial Transplant 2009, 24:512-518. SHARF investigators.
53. Zhao SP, Wu J, Ai YH, Sun B, Xu DM, Guo QL. Comparison of clinical efficacy between continuous veno-venous hemofiltration (CVVH) and CVVH combined with hemoperfusion for the treatment of multiple organ dysfunction syndrome [Chinese]. Chin Crit Care Med 2009, 21:373-374.
54. Lui P, He YZ, Zhang XG, Li G, Wang HC, Lu XX, Zhang CG, Meng QY. Studying the therapic effects of hemoperfusion with continuous venovenous hemofiltration on the patients with acute paraquat poisoning] [Chinese]. Chin J Industrial Hygiene Occupat Dis 2011, 29:266-269.
55. Guo JP, Hu ZJ, Li CX, Li Y, Cui Y, Jia CM. Clinical comparison of efficiency in clearance of interleukin-8 and life of filtrator with continuous venous blood filtration using different proportion of pre- and post-dilution of filtration fluid] [Chinese]. Chin Crit Care Med 2011, 23:189-190.
56. Hubsher J, Olshan AR, Schwartz AB, Zoranski B, DeClement F, Bendlin A, Hensell D, Brezin JH, Krevolin LE, Chinitz JL. Continuous arteriovenous hemofiltration for the treatment of anasarca and acute renal failure in severely burned patients. ASAIO Trans 1986, 32:401-404. 10.1097/00002480-198609000-00002, 3778742.
57. Schetz M. Removal of cytokines in septic patients using continuous veno-venous hemodiafiltration. Crit Care Med 1994, 22:715-716. author reply 719-721.
58. Wakabayashi Y, Kamijou Y, Soma K, Ohwada T. Removal of circulating cytokines by continuous haemofiltration in patients with systemic inflammatory response syndrome or multiple organ dysfunction syndrome. Br J Surg 1996, 83:393-394. 10.1002/bjs.1800830331, 8665203.
59. Hirayama Y, Hirasawa H, Oda S, Shiga H, Nakanishi K, Matsuda K, Nakamura M, Hirano T, Moriguchi T, Watanabe E, Nitta M, Abe R, Nakada T. The change in renal replacement therapy on acute renal failure in a general intensive care unit in a university hospital and its clinical efficacy: a Japanese experience. Ther Apher Dial 2003, 7:475-482. 10.1046/j.1526-0968.2003.00094.x, 14708903.
60. Davenport A, Will EJ, Davison AM. Effect of renal replacement therapy on patients with combined acute renal and fulminant hepatic failure. Kidney Int Suppl 1993, 43:S245-S251.
61. Davenport A, Will EJ, Davison AM. Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema. Contrib Nephrol 1991, 93:225-233.
62. Floris M, Marchionna N, Clementi A, Kim JC, Cruz DN, Nalesso F, Zanella M, Garzotto F, de Cal M, Virzì GM, Brendolan A, Ronco C. Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy. Blood Purif 2011, 32:133-138. 10.1159/000325221, 21654165.
63. Knaus WA, Draper EA, Wagner DP, Zimmermann JE. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829. 10.1097/00003246-198510000-00009, 3928249.
64. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993, 270:2957-2963. [Erratum, JAMA 1994, 271:1321.], 10.1001/jama.1993.03510240069035, 8254858.
65. Ferreira FL, Bota DP, Bross A, Melot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001, 286:1754-1758. 10.1001/jama.286.14.1754, 11594901.
66. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald WJ. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. Crit Care Med 1995, 23:1638-1652. 10.1097/00003246-199510000-00007, 7587228.
67. Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, Leblanc M. Solute clearances during continuous venovenous haemofiltration at various ultrafiltration flow rates using multiflow-100 and HF1000 filters. Nephol Dial Transplant 2003, 18:961-966.
68. Parakininkas D, Greenbaum LA. Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 2004, 5:269-274. 10.1097/01.PCC.0000123554.12555.20, 15115566.
69. Nurmohamed SA, Jallah BP, Vervloet MG, Beishuizen A, Groeneveld ABJ. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin. ASAIO J 2011, 57:48-52. 10.1097/MAT.0b013e318201a599, 21084966.
70. Pannu N, Klarenbach S, Wiebe N, Manns B, Tonelli M, . Alberta Kidney Disease Network Renal replacement therapy in patients with acute renal failure: a systematic review. JAMA 2008, 299:793-805. 10.1001/jama.299.7.793, 18285591, Alberta Kidney Disease Network.
71. Bagshaw SM, Berthiaume LR, Delaney A, Bellomo R. Continuous versus intermittent renal replacement therapy for critically ill patients with acute kidney injury: a meta-analysis. Crit Care Med 2008, 36:610-617. 10.1097/01.CCM.0B013E3181611F552, 18216610.
72. Seabra VF, Balk EM, Liangos O, Sosa MA, Cendoroglo M, Jaber BL. Timing of renal replacement therapy initiation in acute renal failure: a meta-analysis. Am J Kidney Dis 2008, 52:272-284. 10.1053/j.ajkd.2008.02.371, 18562058.
73. Wu M-Y, Hsu Y-H, Bai C-H, Lin Y-F, Wu C-H, Tam K-W. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 2012, 59:810-818. 10.1053/j.ajkd.2011.11.030, 22226564.
74. Phu NH, Hien TT, Mai NTH, Chau TTH, Chuong LV, Loc PP, Winearls C, Farrar J, White N, Day N. Hemofiltration and peritoneal dialysis in infection-associated acute renal failure in Vietnam. N Engl J Med 2002, 347:895-902. 10.1056/NEJMoa020074, 12239258.
75. George J, Varma S, Kumar S, Thomas J, Gopi S, Pisharody R. Comparing continuous venevenous hemodiafiltration and periotoneal dialysis in critically ill patients with acute kidney injury: a pilot study. Perit Dial Int 2011, 31:422-429. 10.3747/pdi.2009.00231, 21357934.
76. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E, . Hemofiltration and Sepsis Group of the College National de Reanimation et de Medecine d'Urgence des Hopitaux extra-Universitaires Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 2009, 37:803-810. 10.1097/CCM.0b013e3181962316, 19237881, Hemofiltration and Sepsis Group of the College National de Reanimation et de Medecine d'Urgence des Hopitaux extra-Universitaires.
77. Sander A, Armbruster W, Sander B, Daul AE, Lange R, Peters J. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNF alpha plasma concentrations. Intensive Care Med 1997, 23:878-884. 10.1007/s001340050425, 9310806.
78. Laurent I, Adrie C, Vinsonneau C, Cariou A, Chiche JD, Ohanessian A, Spaulding C, Carli P, Dhainaut JF, Monchi M. High-volume hemofiltration after out-of-hospital cardiac arrest: a randomized study. J Am Coll Cardiol 2005, 46:432-437. 10.1016/j.jacc.2005.04.039, 16053954.
79. Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hanique G, Matson JR. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28(11):3581-3587. 10.1097/00003246-200011000-00001, 11098957.
80. Arnold DM, Burns KE, Adhikari NK, Kho ME, Meade MO, Cook DJ, . McMaster Critical Care Interest Group The design and interpretation of pilot trials in clinical research in critical care. Crit Care Med 2009, 37(1 Suppl):S69-74. McMaster Critical Care Interest Group.
81. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005, 5:13. 10.1186/1471-2288-5-13, 1097734, 15840177.